# Risk Factors for Hepatic Inflammation, Fibrosis and Prognosis in Patients With CHB and NAFLD

> **NCT05766449** · — · RECRUITING · sponsor: **The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School** · enrollment: 1000 (estimated)

## Conditions studied

- Chronic Hepatitis b
- Non-alcoholic Fatty Liver Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05766449
- **Lead sponsor:** The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-06-01
- **Primary completion:** 2027-03-01
- **Final completion:** 2027-05-01
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2023-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05766449

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05766449, "Risk Factors for Hepatic Inflammation, Fibrosis and Prognosis in Patients With CHB and NAFLD". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05766449. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*